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Introduction
Since in vitro fertilization (IVF) technology, including
sperm preparation techniques, has been developed in
recent years, intrauterine insemination (IUI) appears
to be gaining popularity. It has also been accepted as a
more economical method when compared with other
assisted reproductive techniques.
Currently, the most popular areas for the appli-
cation of IUI in infertility treatment are unexplained
infertility and moderately severe male infertility [1].
When spontaneous pregnancy rates are compared
with timed postcoital pregnancy rates, IUI is found to
significantly increase the pregnancy rates in unexplained
and moderately severe male infertility cases [2]. Also,
the cumulative pregnancy rate following three sequen-
tial cycles of IUI was found to be similar to that with
IVF, and was also reported to be economically benefi-
cial. According to meta-analysis results, single cycle IUI
application, together with ovarian stimulation, resulted
in pregnancy in 16.4% of cases [3,4].
IUI in appropriate patients is a highly satisfactory
treatment modality, taking into account its good results
and low cost.
Materials and Methods
This was a prospective randomized study carried out
in 100 infertile patients. The patients were divided into
two groups. To achieve randomization, the patients who
were admitted during the first and third weeks of every
month were included in the first group, while patients
who were admitted during the second and fourth weeks
of every month were included in the second group. IUI
had not been performed on these patients before, and
this was their first admission. In our study, the patients
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who wanted to have children and had not succeeded in
getting pregnant, despite a regular sexual life for 1 year,
were accepted as infertile and were included in the study.
In all patients included in the study, an anamnesis was
taken; age, the type and duration of infertility, basal
follicle-stimulating hormone (FSH), luteinizing hor-
mone (LH) and estradiol (E2) levels on the third day of
the menstrual cycle, basal ultrasonography on the third
day of the menstrual cycle, spermiogram problems, sys-
temic diseases that could be associated with infertility
(such as hypothyroidism, hyperthyroidism and polycystic
ovarian syndrome) were all recorded and considered.
Patients with a minimum sperm count of 10 million/
cm3, motility criteria of ≥ 40%, i.e. sum of progressive
motility (3+) and (4+), and a normal sperm ratio accord-
ing to Kruger’s strict criteria of ≥ 10% were included in
the IUI program. The body mass indices (BMIs; BMI =
weight [kg]/height [m]2) of all patients were calculated.
Patients included in the study were divided into 
two groups. In the first group of 50 patients, we applied
single IUI 36 hours after 10,000 IU of human chori-
onic gonadotropin (hCG) (Pregnyl, Organon, Istanbul,
Turkey) administration, following ovulation induction.
In the second group of 50 patients, we applied two IUIs
at 24 and 48 hours after 10,000-IU hCG injection, fol-
lowing ovulation induction.
For ovulation induction, our first choice was clomi-
phene citrate, but some patients who were resistant to
clomiphene citrate were induced with gonadotropins.
The ratio of patients induced with each method was simi-
lar in the two groups. During ovulation induction with
clomiphene citrate (Klomen, Koçak, Istanbul, Turkey),
we started the drug on the fifth day of the menstrual
cycle with the minimum dose (50 mg/day) for 5 days. In
patients not responding to this dose, we increased the
dosage by 50 mg in each cycle, up to 150 mg/day.
Recombinant FSH (Gonal-F, Serono, Istanbul, Turkey)
was used for ovulation induction in the gonadotropin
group.
Ovulation induction was initiated on the third day
of the menstrual cycle with 75 IU/day of recombinant
FSH and was continued by increasing the dose until an
18-mm follicle was detected.
All patients were followed up by folliculometry.
Ovulation was triggered by 10,000 IU of hCG when 
the follicular diameter, measured by ultrasonography,
reached 18–22 mm in patients treated with either
clomiphene citrate or gonadotropins.
The semen sample needed for insemination was pre-
pared by swim-up technique. In the first group, insemina-
tion was carried out 36 hours after hCG administration;
whereas in the second group, two inseminations were
carried out at 24 and 48 hours after hCG administra-
tion. Insemination was performed in the lithotomy posi-
tion via an IUI catheter (Gynetics Medical Products N.V.,
Hamont-Achel, Belgium) after the vagina and the cervix
had been washed with isotonic solution. During the
procedure, the cervix was not held with a grasper unless
definitely necessary. After the procedure, the patients
rested on the treatment table for up to 30–40 minutes.
All patients were tested for serum β-hCG levels on
the fourteenth day following the predicted ovulation day.
Clinical pregnancy was detected by the demonstration of
fetal cardiac activity by transvaginal ultrasonography.
The statistical significance of the results was evalu-
ated using the SPSS version 11.0 (SPSS Inc., Chicago, IL,
USA) for Windows software. The data were defined by
mean and standard deviation. Comparisons of data were
carried out using Chi-squared tests and Fisher’s exact
test. Statistical significance was accepted at p < 0.05.
Results
One hundred patients, 50 in the first group and 50 in
the second group, were included in the study. There
was no statistically significant difference between the
two groups according to age, the duration of infertility
or body mass indices (p > 0.05). When both groups
were evaluated for hormone levels, there were no sta-
tistically significant differences in FSH, LH or E2 (p >
0.05). The ages, mean FSH, LH and E2 levels, body
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Table 1. Patient age, duration of infertility, body mass index, mean follicle-stimulating hormone (FSH), luteinizing hormone
(LH) and estradiol (E2) levels in both groups
Group 1 Group 2 p
Age (yr) 29.22 ± 3.73 29.96 ± 4.67 NS
Duration of infertility (yr) 4.72 ± 3.27 4.26 ± 2.08 NS
Body mass index (kg/m2) 26.10 ± 2.85 25.02 ± 1.82 NS
FSH (mIU/mL) 5.40 ± 2.26 5.18 ± 2.08 NS
LH (mIU/mL) 4.54 ± 2.23 4.82 ± 2.54 NS
E2 (pg/mL) 40.04 ± 15.46 42.04 ± 15.87 NS
NS = not significant (p > 0.05).
mass indices and durations of infertility for patients 
in both groups are shown in Table 1.
In 35 patients in the first group, we detected female
factor infertility (70%), whilst in the remaining 15 cases,
there was male factor infertility (30%). In the second
group, 30 patients demonstrated female factor infer-
tility (60%) and the remaining 20 patients male factor
infertility (40%). Table 2 details the types of infertility
and their causes. When both groups were compared
for the type of infertility and the causes, there was 
no statistically significant difference between them with
univariate analysis (p > 0.05).
Ovulation induction was performed with clomiphene
citrate in 58 of the patients included in the study (58%),
whilst gonadotropins were used for the remaining 
42 patients (42%). In the first group, 29 patients were
induced with clomiphene citrate (58%), and 21 patients
were induced with gonadotropins (42%); in the sec-
ond group, ovulation was induced with clomiphene
citrate in 29 patients (58%), and with gonadotropins
in 21 patients (42%). In our study, there was no statis-
tically significant difference according to the agents
used for ovulation induction (p > 0.05).
Seventy-five cycles and 78 cycles of ovulation induc-
tion were carried out in the first and second groups,
respectively. No patient in either group had more than
two cycles of ovulation induction, and there was no sta-
tistically significant difference between the two groups
in the number of cycles of ovulation induction performed
(p > 0.05). When we look at the results after  IUI per-
formed following ovulation induction, eight pregnan-
cies were detected in the first group (pregnancy rate
per patient, 16%; per cycle, 10%); no pregnancy was
detected in the remaining 42 patients (84%). Five preg-
nancies were detected in the second group (pregnancy
rate per patient, 10%; per cycle, 6.4%); no pregnancy
occurred in the remaining 45 patients (90%). There
was no statistically significant difference (p >0.05) in
pregnancy rates between the different insemination
procedures. The results of the procedures are shown 
in Table 3.
Discussion
Five basic tests were defined for the investigation of
infertile couples in the American Fertility Society 1992
and World Health Organization (WHO) 1993 meetings:
semen analysis, the evaluation of ovulation, the evalu-
ation of the patency of the uterus and the tubes, the
postcoital test, and laparoscopy [5,6]. In evaluating
infertile couples in this study, we checked spermiograms,
ovulation, basal FSH, LH and E2 levels on the third day
of the menstrual cycle, basal ultrasonography on the
third day of menses, hysterosalpingography, and lapa-
roscopy, when necessary. Among the basic tests for the
evaluation of infertile couples, only the postcoital test
was not performed in our study. The postcoital test was
not performed because of the unknown effects of this
test on prognosis in large and controlled studies, and
because IUI was already planned for these patients.
In the treatment of infertility, expectant management
or active treatment modalities, or sometimes both, can
be used. Expectant management is offered especially
for young patients who have experienced a short dura-
tion of unexplained infertility; in 60% of these cases,
pregnancies develop within 2 years [7].
Among the active treatment modalities, IUI appears
to be an alternative method which, together with the
development of sperm preparation techniques, parallels
developments in assisted reproductive technology within
the last 20 years. Currently, in most clinics, patients with-
out tubal infertility are taken into an IVF program after a
few trials of IUI. Compared with the low pregnancy rates
reported previously, the currently reported pregnancy
rates are high. Both the increase in the sperm concen-
tration and the increase in the number of oocytes as a
result of superovulation play a role in this success.
Freundl [8] offered assisted reproductive techniques
to patients who failed to become pregnant after four
cycles of treatment with IUI. In this study, a maximum
of two cycles of IUI was performed in the patients.
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Table 2. Types of infertility and the reasons in both groups
Types of infertility and Group 1, Group 2, 
p
the reasons n (%) n (%)
Female factors 35 (70) 30 (60) NS
Anovulation 16 (32) 9 (18) NS
Endometriosis 6 (12) 7 (14) NS
Unexplained 13 (26) 14 (28) NS
Male factors 15 (30) 20 (40) NS
Oligospermia 12 (24) 15 (30) NS
Oligoasthenospermia 3 (6) 5 (10) NS
NS = not significant (p > 0.05).
Table 3. Outcomes of intrauterine insemination in patients 
from both groups
Group 1 Group 2 Total p
Pregnancy (+) 8 5 13
Pregnancy (−) 42 45 87 NS
Total 50 50 100
NS = not significant (p > 0.05).
The study by Kang et al [9] supported the impor-
tance of the female age in the success of IUI and reported
the fertility rate of 20% in women aged 35 years and
younger, 12% in patients aged 35 to 40 years and 6% in
patients aged 40 years and older. In our study, the mean
age of the patients in the first group was 28.76 ± 4.49
years (range, 22–38 years) and in the second group,
this was 28.44 ± 5.53 years (range, 19–38 years).
Collins et al [10] emphasized the importance of the
duration of infertility on the prognosis and reported
that the cumulative pregnancy rate decreased by 2%
each year in patients 25 years old or older, with infertil-
ity duration of 3 years or longer. In this study, the mean
duration of infertility was 4.76 ± 3.84 years (range,
2–18 years) in the first group and 3.74 ± 2.68 years
(range, 1–11 years) in the second group.
Another factor affecting the prognosis of infertility
treatment is body mass index. The range of body mass
indices that is accepted as normal and that is not known
to affect ovulatory function is 20–25 [11]. Wittemer 
et al [12] reported that the chance of pregnancy
decreased when the body mass index was below 20 or
above 25.
Several reports in the literature demonstrate an
increase in pregnancy rates due to IUI following ovula-
tion induction by clomiphene citrate or gonadotropins
[13–15].
According to the WHO criteria, the lowest normal
sperm count is accepted to be 20 million/cm3. In some
studies, the sperm count was found to be below 20 mil-
lion/cm3 in more than 25% of fertile males [16].
Delepine et al [17] reported that the sperm count
was a factor in the IUI success and that the highest
pregnancy rates were observed in patients in which
5–10 million/cm3 of spermatozoa were inseminated.
In this study, the patients with a minimum sperm count
of 10 million/cm3, motility criteria of ≥ 40%, i.e. the sum
of (3 +) and (4 +), and normal sperm ratio according
to Kruger’s strict criteria of ≥ 10% were included in the
IUI program.
The timing of insemination is also important in IUI
treatment. Deaton et al [18] induced patients with
clomiphene citrate, and performed IUI according to
urinary LH monitoring in one group and according to
ultrasonographic monitoring and hCG administration
in the second group. When the two groups were com-
pared for pregnancy rates, there was no statistically
significant difference. In our study, ultrasonographic
monitoring and hCG administration was used for the
timing of IUI.
Ragni et al [19] induced cycles with clomiphene cit-
rate or gonadotropins, and applied IUI 34 hours after
hCG administration in the first group, two IUIs 12 and
34 hours after hCG administration in the second group
and two IUIs 34 and 60 hours after hCG administra-
tion in the third group. The pregnancy rate was found
to be 14.4% per patient and 8.3% per cycle in the first
group, and 30.4% per patient and 6.7% per cycle in the 
second group.
Silverberg et al [20] reported that the fertility rate
was higher when insemination was done 18 and 42
hours after hCG administration following ovulation
induction, when compared with a single insemination
performed 34 hours after hCG administration.
In their ovulation induction cycles, Matilsky et al [21]
applied single IUI 24 hours after hCG administration
in the first group and two IUIs 24 and 48 hours after
hCG administration in the second group. The preg-
nancy rate was 9.7% per patient and 5% per cycle in
the first group and 37.9% per patient and 17.9% per
cycle in the second group.
Cantineau et al [22] reported that double IUI had
no advantage over single IUI. Zeyneloğlu [23] reported
that double IUI has been suggested to increase effi-
ciency, but recent studies have not confirmed this find-
ing. Alborzi et al [24] reported that amongst patients
undergoing controlled ovarian hyperstimulation with
IUI, the results of single and double IUI did not differ
statistically.
When we looked at the results of IUI after ovula-
tion induction in this study, fetal cardiac activity was
detected in eight patients (16%) in the first group, while
in the remaining 42 patients (84%), pregnancy was not
achieved. In the second group, 5 patients (10%) showed
fetal cardiac activity, but in the remaining 45 patients
(90%), pregnancy was not achieved. Timing and num-
ber of IUIs had no statistically significant effect on
pregnancy (p > 0.05).
In conclusion, a single IUI application can be more
desirable than double insemination, taking into account
the cost and psychologic trauma caused to the cou-
ples both during sperm donation and applications 
of repeated IUIs. However, further studies with larger
sample sizes are needed in order to reveal any actual
differences between the two methods.
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